9
www.technavio.com enquiry@technavio .com Global Biobanking Market 2015-2019

Global Biobanking Market 2015-2019

Embed Size (px)

Citation preview

[email protected]

Global Biobanking Market 2015-2019

Covered in this Report• The Global Biobanking market can be divided into two

segments: Equipment and Consumables.

• This report covers the present scenario and the growth prospects of the Global Biobanking market for the period 2015-2019.

• Technavio's report, Global Biobanking Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

• The report covers the Americas, and the EMEA and APAC regions; it also covers the market landscape and its growth prospects in the coming years.

• The report also includes a discussion of the key vendors operating in this market.

Global Biobanking Market 2015-2019

USA – CANADA – UK – CHINA – INDIA

Market Overview• Biobank is a biorepository for the preservation and collection

of biological material used for diagnosis, biodiversity studies, and research.

• Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.

• The human biobanks work by systematic collection of biological samples from patients and other members of the public.

• Biobanks significantly vary in size such as biobanks held in medical institutions hold relatively modest number of samples compared with a national biobank, which hold a large number of samples.

• Technavio's analysts forecast the Global Biobanking market to grow at a CAGR of 7.07 percent over the period 2014-2019.

To know more aboutGlobal Biobanking Market 2015-2019,

please mail us [email protected]

USA – CANADA – UK – CHINA – INDIA

Key Findings

• Strategic Alliances• Biobanks support key breakthroughs in drug discovery, scientific research, and

clinical translational medicine, which make sample handling and cold chain management their top priority.

• Advances in IT• Researchers can now handle thousands of specimens and thousands of

megabytes of data for each specimen through powerful tools and software. The electronic record systems help experts gain access to samples and study their genotypic and phenotypic information.

• Initiatives in Rare Diseases Research• The increase in research on rare and complex diseases will require the

collection of more biospecimens. In addition, the focus on orphan drug manufacturing will require more samples for clinical trials.

USA – CANADA – UK – CHINA – INDIA

Key Questions Answered in Our Report

• What will the market size be in 2019 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

Have a question of your own about this report?

Ask our Analysts

USA – CANADA – UK – CHINA – INDIA

• Decision makers and influencers in sales & marketing, strategy, product and R&D teams rely on research from Technavio. We have a large and growing base of happy customers worldwide. Our customers include technology suppliers, end users, consulting companies, investment firms and research institutes.

• Technavio was founded in 2003 in London. We have about 300 analysts globally. We cover more than 500 technologies across 80 countries. Traditional media such as Forbes Asia and New York Times, along with other web media portals, like to quote us.

About Technavio

Some of our clients include:ACT Global, Flextronics, Huawei Technologies Co, Infosys, Harris Corporation, Infosys, Intercad, Hidaka Precision Tools & Dies Company, Huawei Technologies Co, American Capital, Analysis Group, Netscout, NTT DoCoMo

USA – CANADA – UK – CHINA – INDIA

Thank You!

Mail us at: [email protected] can visit us at:www.technavio.com

USA – CANADA – UK – CHINA – INDIA